219A Share Price Performance
JP¥0
-2048.00 (-100.00%)
Price JP¥0
Share Pricen/a
Heartseed Inc. Stock Price
- 0 Narratives written by author
- 0 Comments on narratives written by author
- 0 Fair Values set on narratives written by author
219A Community Narratives
There are no narratives available yet.
There are no community narratives available.
Trending Discussion
Recently Updated Narratives
No recently updated narratives available.
Snowflake Analysis
Heartseed Inc. Key Details
About 219A
- Founded
- 2015
- Employees
- n/a
- CEO
- WebsiteView website
Heartseed Inc. develops and commercializes iPS cell-derived cardiomyocyte replacement therapy for heart failure. The company’s lead product is HS-001 for heart failure with reduced ejection fraction indications, including dilated cardiomyopathy, old myocardial infraction, and dilated phase of hypertrophic cardiomyopathy. It also develops products using autologous iPSC and HLA knock-out iPSC. The company was incorporated in 2015 and is headquartered in Tokyo, Japan.
